Nunzia Pharmaceutical Corp. (NUNZ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Nunzia Pharmaceutical Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | 0.2267M |
| June 30, 2022 | 0.1473M |
| March 31, 2022 | 0.1373M |
| December 31, 2021 | 0.0993M |
| September 30, 2021 | 0.0977M |
| June 30, 2021 | 0.0857M |
| March 31, 2021 | 0.0917M |
| December 31, 2020 | 0.0594M |
| September 30, 2020 | 0.0291M |
| June 30, 2020 | 0.0271M |
| March 31, 2020 | 0.0258M |
| December 31, 2019 | 0.0226M |
| September 30, 2019 | 0.3163M |
| June 30, 2019 | 0.315M |
| March 31, 2019 | 0.3002M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | 0.1946M |
| March 31, 2018 | 0.1946M |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 |
| Date | Value |
|---|---|
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Herborium Group, Inc. | 2.913M |
| Entia Biosciences, Inc. | -- |
| Trident Brands, Inc. | -- |
| Medifast, Inc. | 64.02M |
| Joey New York, Inc. | -- |